Newly Approved Shingles Vaccine receives ACIP preference

on Oct 25, 2017 in news



The Advisory Committee on Immunization Practices (ACIP) gives their recommendation and preference of Shingvax vaccine over current shingles vaccine, Zostavax.  This vote was due to the impressive 90% efficacy demonstrated by Shingvax.  This information will be published in the upcoming issue of the Morbidity and Mortality Weekly Report.  Read more